<SEC-DOCUMENT>0001396814-22-000053.txt : 20220804
<SEC-HEADER>0001396814-22-000053.hdr.sgml : 20220804
<ACCEPTANCE-DATETIME>20220804163920
ACCESSION NUMBER:		0001396814-22-000053
CONFORMED SUBMISSION TYPE:	S-8
PUBLIC DOCUMENT COUNT:		6
FILED AS OF DATE:		20220804
DATE AS OF CHANGE:		20220804
EFFECTIVENESS DATE:		20220804

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Pacira BioSciences, Inc.
		CENTRAL INDEX KEY:			0001396814
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		IRS NUMBER:				510619477
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		S-8
		SEC ACT:		1933 Act
		SEC FILE NUMBER:	333-266532
		FILM NUMBER:		221137297

	BUSINESS ADDRESS:	
		STREET 1:		5401 WEST KENNEDY BOULEVARD
		STREET 2:		SUITE 890
		CITY:			TAMPA
		STATE:			FL
		ZIP:			33609
		BUSINESS PHONE:		813-553-6680

	MAIL ADDRESS:	
		STREET 1:		5 SYLVAN WAY
		STREET 2:		SUITE 300
		CITY:			PARSIPPANY
		STATE:			NJ
		ZIP:			07054

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	Pacira Pharmaceuticals, Inc.
		DATE OF NAME CHANGE:	20101029

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	PACIRA INC
		DATE OF NAME CHANGE:	20080318

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	Blue Acquisition Corp
		DATE OF NAME CHANGE:	20070418
</SEC-HEADER>
<DOCUMENT>
<TYPE>S-8
<SEQUENCE>1
<FILENAME>s-8esppregistrationaugust2.htm
<DESCRIPTION>S-8
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2022 Workiva -->
<title>Document</title></head><body><div id="id6e986e382c6447fad4faf541be14f4e_59"></div><div style="min-height:50.4pt;width:100%"><div style="padding-left:9pt;padding-right:9pt;text-align:center;text-indent:36pt"><font><br></font></div></div><div style="padding-left:9pt;padding-right:9pt;text-align:center;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:155%">As filed with the Securities and Exchange Commission on August 4, 2022</font></div><div style="padding-right:18pt;text-align:right;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:155%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;  Registration No. 333-</font></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:3pt"><td colspan="3" style="background-color:#000000;padding:0 1pt"></td></tr><tr style="height:3pt"><td colspan="3" style="border-bottom:1pt solid #000000;padding:0 1pt"></td></tr></table></div><div style="padding-left:18pt;padding-right:18pt;text-align:center"><font><br></font></div><div style="padding-left:18pt;padding-right:18pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">UNITED STATES</font></div><div style="padding-left:18pt;padding-right:18pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">SECURITIES AND EXCHANGE COMMISSION</font></div><div style="padding-left:18pt;padding-right:18pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">Washington, D.C. 20549</font></div><div style="padding-left:18pt;padding-right:18pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">______________________</font></div><div style="margin-bottom:6pt;margin-top:6pt;padding-left:18pt;padding-right:18pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:18pt;font-weight:700;line-height:120%">FORM S-8</font></div><div style="padding-left:18pt;padding-right:18pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">REGISTRATION STATEMENT UNDER THE</font></div><div style="padding-left:18pt;padding-right:18pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">SECURITIES ACT OF 1933</font></div><div style="margin-bottom:6pt;padding-left:18pt;padding-right:18pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">______________________</font></div><div style="padding-left:18pt;padding-right:18pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:18pt;font-weight:700;line-height:120%">PACIRA BIOSCIENCES, INC.</font></div><div style="margin-bottom:6pt;padding-left:18pt;padding-right:18pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">(Exact name of registrant as specified in its charter)</font></div><div style="padding-left:18pt;padding-right:18pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:294.00pt"><tr><td style="width:1.0pt"></td><td style="width:190.75pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:99.25pt"></td><td style="width:1.0pt"></td></tr><tr style="height:14pt"><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Delaware</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">51-0619477</font></td></tr><tr style="height:24pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="padding-left:2.75pt;padding-right:2.75pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">(State or other jurisdiction of</font></div><div style="padding-left:2.75pt;padding-right:2.75pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">incorporation or organization)</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="padding-left:2.75pt;padding-right:2.75pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">(I.R.S. Employer</font></div><div style="padding-left:2.75pt;padding-right:2.75pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">Identification No.)</font></div></td></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:24pt"><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="padding-left:38.75pt;padding-right:38.75pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">5401 West Kennedy Boulevard, Suite 890</font></div><div style="padding-left:19.37pt;padding-right:19.37pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Tampa, Florida 33609</font></div></td></tr><tr style="height:14pt"><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(Address and zip code of principal executive offices)</font></td></tr></table></div><div style="padding-left:36pt;padding-right:36pt;text-align:center"><font><br></font></div><div style="padding-left:9pt;padding-right:9pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Pacira BioSciences, Inc. Amended and Restated 2014 Employee Stock Purchase Plan<br></font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">(Full title of the plan)</font></div><div style="padding-left:18pt;padding-right:18pt;text-align:center"><font><br></font></div><div style="padding-left:18pt;padding-right:18pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">David Stack </font></div><div style="padding-left:18pt;padding-right:18pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Chief Executive Officer and Chairman</font></div><div style="padding-left:18pt;padding-right:18pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Pacira BioSciences, Inc. </font></div><div style="padding-left:18pt;padding-right:18pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">5401 West Kennedy Boulevard, Suite 890</font></div><div style="padding-left:18pt;padding-right:18pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Tampa, Florida 33609</font></div><div style="padding-left:18pt;padding-right:18pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">(Name and address of agent for service)</font></div><div style="padding-left:18pt;padding-right:18pt;text-align:center"><font><br></font></div><div style="padding-left:18pt;padding-right:18pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(813) 553-6680</font></div><div style="padding-left:18pt;padding-right:18pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">(Telephone number, including area code, of agent for service)</font></div><div style="margin-bottom:3pt;padding-left:18pt;padding-right:18pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">______________________<br>Copy to&#58;</font></div><div style="padding-left:2.75pt;padding-right:2.75pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Jason Day</font></div><div style="padding-left:2.75pt;padding-right:2.75pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Ned A. Prusse</font></div><div style="padding-left:2.75pt;padding-right:2.75pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Perkins Coie LLP</font></div><div style="padding-left:2.75pt;padding-right:2.75pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">1900 Sixteenth Street, Suite 1400</font></div><div style="padding-left:2.75pt;padding-right:2.75pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Denver, Colorado 80202</font></div><div style="margin-bottom:6pt;padding-left:2.75pt;padding-right:2.75pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(303) 291-2300</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, smaller reporting company, or an emerging growth company.  See the definitions of &#8220;large accelerated filer,&#8221; &#8220;accelerated filer,&#8221; &#8220;smaller reporting company,&#8221; and &#8220;emerging growth company&#8221; in Rule&#160;12b-2 of the Exchange Act&#58; </font></div><div><font><br></font></div><div style="padding-left:32.2pt;padding-right:32.2pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:284.25pt"><tr><td style="width:1.0pt"></td><td style="width:98.50pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:18.25pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:7.75pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:132.25pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:17.50pt"></td><td style="width:1.0pt"></td></tr><tr style="height:14pt"><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Large accelerated filer</font></td><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Wingdings',sans-serif;font-size:12pt;font-weight:400;line-height:100%">x</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accelerated filer</font></td><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Wingdings',sans-serif;font-size:12pt;font-weight:400;line-height:100%">o</font></td></tr><tr style="height:14pt"><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-accelerated filer</font></td><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Wingdings',sans-serif;font-size:12pt;font-weight:400;line-height:100%">o</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Smaller reporting company</font></td><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Wingdings',sans-serif;font-size:12pt;font-weight:400;line-height:100%">o</font></td></tr><tr style="height:14pt"><td colspan="9" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Emerging growth company</font></td><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Wingdings',sans-serif;font-size:12pt;font-weight:400;line-height:100%">o</font></td></tr></table></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 7(a)(2)(B) of the Securities Act.  </font><font style="color:#000000;font-family:'Wingdings',sans-serif;font-size:12pt;font-weight:400;line-height:100%">o</font></div><div style="height:50.4pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </font></div></div></div><div id="id6e986e382c6447fad4faf541be14f4e_62"></div><hr style="page-break-after:always"><div style="min-height:50.4pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">EXPLANATORY NOTE</font></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;This registration statement on Form S-8 is filed by Pacira BioSciences, Inc. relating to 500,000 additional shares of common stock, par value $0.001 per share, authorized to be issued pursuant to the Pacira BioSciences, Inc. Amended and Restated 2014 Employee Stock Purchase Plan.</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">PART II</font></div><div style="text-align:center"><font><br></font></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">INFORMATION REQUIRED IN REGISTRATION STATEMENT</font></div><div style="margin-bottom:12pt;padding-left:36pt;padding-right:36pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 3.&#160;&#160;&#160;&#160;Incorporation of Documents by Reference.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following documents filed with the Securities and Exchange Commission (the &#8220;SEC&#8221;) are hereby incorporated by reference in this registration statement&#58;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(1)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.34pt">The registrant&#8217;s </font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a href="http://www.sec.gov/ix?doc=/Archives/edgar/data/1396814/000139681422000021/pcrx-20211231.htm" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Annual Report on Form 10-K for the fiscal year ended December 31, 2021</a></font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, filed with the SEC on February 28, 2022&#59;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(2)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.34pt">The registrant&#8217;s Quarterly Reports on Form 10-Q for the quarters ended </font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a href="http://www.sec.gov/ix?doc=/Archives/edgar/data/1396814/000139681422000033/pcrx-20220331.htm" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">March 31, 2022</a></font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> and </font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a href="http://www.sec.gov/ix?doc=/Archives/edgar/data/1396814/000139681422000050/pcrx-20220630.htm" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">June 30, 202</a><a href="http://www.sec.gov/ix?doc=/Archives/edgar/data/1396814/000139681422000050/pcrx-20220630.htm" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">2</a></font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, filed with the SEC on May 4, 2022 and August 3, 2022, respectively&#59;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(3)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.34pt">The registrant&#8217;s Current Reports on Form 8-K filed with the SEC on </font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a href="http://www.sec.gov/ix?doc=/Archives/edgar/data/1396814/000139681422000009/pcrx-20211119.htm" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">February 7, 2022</a></font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, </font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a href="http://www.sec.gov/ix?doc=/Archives/edgar/data/1396814/000139681422000031/pcrx-20220504.htm" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">May 4, 2022</a></font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> and </font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a href="http://www.sec.gov/ix?doc=/Archives/edgar/data/1396814/000139681422000038/pcrx-20220607.htm" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">June 10, 2022</a></font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#59; and </font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(4)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.34pt">The description of the registrant&#8217;s common stock contained in the registrant&#8217;s Registration Statement on Form 8-A filed with the SEC on January 28, 2011</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">under Section 12(b) of the Securities Exchange Act of 1934, as amended (the &#8220;Exchange Act&#8221;), including any amendments or reports filed for the purpose of updating such description (including </font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a href="https://www.sec.gov/Archives/edgar/data/0001396814/000139681420000008/pcrx-12312019xex43.htm" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Exhibit 4.3 to the registrant&#8217;s Annual Report on Form 10-K for the fiscal year ended December 31, 2019</a></font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, filed with the SEC on February 21, 2020.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">All documents filed by the registrant pursuant to Section&#160;13(a), 13(c), 14 or 15(d) of the Securities Exchange Act of 1934, as amended (the &#8220;Exchange Act&#8221;), after the date hereof, and prior to the filing of a post-effective amendment that indicates that all the securities offered hereby have been sold or that deregisters the securities offered hereby then remaining unsold, shall also be deemed to be incorporated by reference into this registration statement and to be a part hereof from the date of filing of such documents&#59;&#160;</font><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">provided</font><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">,</font><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> however</font><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, that documents or information deemed to have been furnished and not filed in accordance with the rules of the Commission shall not be deemed incorporated by reference in this registration statement.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Any statement contained in this registration statement or in a document incorporated or deemed to be incorporated by reference in this registration statement will be deemed to be modified or superseded to the extent that a statement contained herein or in any other subsequently filed document which also is or is deemed to be incorporated by reference in this registration statement modifies or supersedes that statement.  Any statement so modified or superseded will not be deemed, except as so modified or superseded, to constitute a part of this registration statement.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 4.&#160;&#160;&#160;&#160;Description of Securities.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Not applicable.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 5.&#160;&#160;&#160;&#160;Interests of Named Experts and Counsel.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">None.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 6.&#160;&#160;&#160;&#160;Indemnification of Directors and Officers.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Section 145 of the General Corporation Law of the State of Delaware (the &#8220;DGCL&#8221;) provides, generally, that a corporation shall have the power to indemnify any person who was or is a party or is threatened to be made a party to any threatened, pending or completed action, suit or proceeding (except actions by or in the right of the corporation) by reason of the fact that such person is or was a director, officer, employee or agent of the corporation against all expenses, judgments, fines and </font></div><div style="height:50.4pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </font></div></div></div><hr style="page-break-after:always"><div style="min-height:50.4pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">amounts paid in settlement actually and reasonably incurred by such person in connection with such action, suit or proceeding if such person acted in good faith and in a manner such person reasonably believed to be in or not opposed to the best interests of the corporation and, with respect to any criminal action or proceeding, had no reasonable cause to believe his or her conduct was unlawful.  A corporation may similarly indemnify such person for expenses actually and reasonably incurred by such person in connection with the defense or settlement of any action or suit by or in the right of the corporation, provided that such person acted in good faith and in a manner he or she reasonably believed to be in or not opposed to the best interests of the corporation, and, in the case of claims, issues and matters as to which such person shall have been adjudged liable to the corporation, provided that a court shall have determined, upon application, that, despite the adjudication of liability but in view of all of the circumstances of the case, such person is fairly and reasonably entitled to indemnity for such expenses which such court shall deem proper. </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Section 102(b)(7) of the DGCL provides, generally, that the registrant&#8217;s amended and restated certificate of incorporation may contain a provision eliminating or limiting the personal liability of a director to the corporation or its shareholders for monetary damages for breach of fiduciary duty as a director,  provided that such provision may not eliminate or limit the liability of a director (i) for any breach of the director's duty of loyalty to the corporation or its shareholders, (ii) for acts or omissions not in good faith or which involve intentional misconduct or a knowing violation of law, (iii) under section 174 of the DGCL, or (iv) for any transaction from which the director derived an improper personal benefit.  No such provision may eliminate or limit the liability of a director for any act or omission occurring prior to the date when such provision became effective. </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition to the indemnification provided for in the registrant&#8217;s amended and restated certificate of incorporation and amended and restated bylaws, the registrant entered into indemnification agreements with each of its directors and executive officers.  Each indemnification agreement provides that the registrant will indemnify the director or executive officer to the fullest extent permitted by law for claims arising in his or her capacity as a director, officer, employee or agent, provided that he or she acted in good faith and in a manner that he or she reasonably believed to be in, or not opposed to, our best interests and, with respect to any criminal proceeding, had no reasonable cause to believe that his or her conduct was unlawful. In the event that the registrant does not assume the defense of a claim against a director or executive officer, the registrant is required to advance his or her expenses in connection with his or her defense, provided that he or she undertakes to repay all amounts advanced if it is ultimately determined that he or she is not entitled to be indemnified by the registrant.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:139%">Item 7.&#160;&#160;&#160;&#160;Exemption from Registration Claimed.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">Not applicable.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:139%">Item 8.&#160;&#160;&#160;&#160;Exhibits.</font></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:94.630%"><tr><td style="width:1.0%"></td><td style="width:15.024%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:82.776%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Exhibit No.</font></td><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Description</font></td></tr><tr><td colspan="3" style="border-top:0.75pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.1</font></td><td colspan="3" style="border-top:0.75pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.77pt"><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a href="s-8exhibit51.htm" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">Opinion of Perkins Coie LLP.</a></font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23.1</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.77pt"><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a href="s-8exhibit231.htm" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">Consent of KPMG LLP.</a></font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23.2</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.77pt"><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a href="exhibit232.htm" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">Consent of PricewaterhouseCoopers LLP.</a></font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23.3</font></td><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Consent of Perkins Coie LLP (included in Exhibit 5.1).</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24.1</font></td><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Power of Attorney (see signature page of this Registration Statement).</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">99.1</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-top:6pt;padding-left:2.75pt;padding-right:2.75pt"><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a href="http://www.sec.gov/Archives/edgar/data/1396814/000139681422000038/exhibit1016-7x22.htm" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">Pacira BioSciences, Inc. Amended and Restated 2014 Employee Stock Purchase Plan (incorporated by reference to Exhibit 10.1 of the registrant&#8217;s Current Report on Form 8-K filed on June 10, 2022).</a></font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">107</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.75pt"><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a href="exhibit107s-8aug2022.htm" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">Filing Fee Table.</a></font></div></td></tr></table></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><font><br></font></div><div style="height:50.4pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </font></div></div></div><hr style="page-break-after:always"><div style="min-height:50.4pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 9.&#160;&#160;&#160;&#160;Undertakings.</font></div><div style="margin-bottom:12pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A.  The undersigned registrant hereby undertakes&#58;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:48.95pt"><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(1) To file, during any period in which offers or sales are being made, a post-effective amendment to this registration statement&#58;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:79.55pt"><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(a) To include any prospectus required by Section&#160;10(a)(3) of the Securities Act&#59;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:79.55pt"><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(b) To reflect in the prospectus any facts or events arising after the effective date of this registration statement (or the most recent post-effective amendment thereof) which, individually or in the aggregate, represent a fundamental change in the information set forth in this registration statement&#59; and</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:79.55pt"><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(c) To include any material information with respect to the plan of distribution not previously disclosed in this registration statement or any material change to such information in this registration statement&#59;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:79.55pt"><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">provided</font><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">,&#160;</font><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">however</font><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, that paragraphs&#160;(1)(a) and (1)(b)&#160;above do not apply if the information required to be included in a post-effective amendment by those paragraphs is contained in reports filed with or furnished to the Commission by the registrant pursuant to Section&#160;13 or Section&#160;15(d) of the Exchange Act that are incorporated by reference in this registration statement.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:48.95pt"><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(2) That, for the purpose of determining any liability under the Securities Act, each such post-effective amendment shall be deemed to be a new registration statement relating to the securities offered therein, and the offering of such securities at that time shall be deemed to be the initial bona fide offering thereof.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:48.95pt"><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(3) To remove from registration by means of a post-effective amendment any of the securities being registered which remain unsold at the termination of the offering.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:24.5pt"><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">B.  The undersigned registrant hereby undertakes that, for purposes of determining any liability under the Securities Act, each filing of the registrant&#8217;s annual report pursuant to Section&#160;13(a) or 15(d) of the Exchange Act (and, where applicable, each filing of an employee benefit plan&#8217;s annual report pursuant to Section&#160;15(d) of the Exchange Act) that is incorporated by reference in this registration statement shall be deemed to be a new registration statement relating to the securities offered therein, and the offering of such securities at that time shall be deemed to be the initial bona fide offering thereof.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:24.5pt"><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">C.  Insofar as indemnification for liabilities arising under the Securities Act may be permitted to directors, officers and controlling persons of the registrant pursuant to the foregoing provisions, or otherwise, the registrant has been advised that, in the opinion of the Commission, such indemnification is against public policy as expressed in the Securities Act and is, therefore, unenforceable. In the event that a claim for indemnification against such liabilities (other than the payment by the registrant of expenses incurred or paid by a director, officer or controlling person of the registrant in the successful defense of any action, suit or proceeding) is asserted by such director, officer or controlling person in connection with the securities being registered, the registrant will, unless in the opinion of its counsel the matter has been settled by controlling precedent, submit to a court of appropriate jurisdiction the question whether such indemnification by it is against public policy as expressed in the Securities Act and will be governed by the final adjudication of such issue.</font></div><div style="margin-bottom:12pt;text-align:justify"><font><br></font></div><div style="margin-bottom:12pt;text-align:justify"><font><br></font></div><div style="height:50.4pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </font></div></div></div><div id="id6e986e382c6447fad4faf541be14f4e_65"></div><hr style="page-break-after:always"><div style="min-height:50.4pt;width:100%"><div><font><br></font></div></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">SIGNATURES </font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">&#160;</font></div><div style="text-align:justify;text-indent:24pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Pursuant to the requirements of the Securities Act of 1933, the registrant certifies that it has reasonable grounds to believe that it meets all of the requirements for filing on Form S-8 and has duly caused this registration statement to be signed on its behalf by the undersigned, thereunto duly authorized, in the City of Tampa, State of Florida, on August 4, 2022. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">&#160;</font></div><div style="text-indent:24.5pt"><font><br></font></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:95.950%"><tr><td style="width:1.0%"></td><td style="width:51.193%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:1.958%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:43.549%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">PACIRA BIOSCIENCES, INC.</font></td></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#160;&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">&#47;s&#47; David Stack</font></div><div style="padding-left:7.25pt;padding-right:7.25pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">David Stack</font></div><div style="margin-bottom:6pt;padding-left:7.55pt;padding-right:7.55pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Chief Executive Officer and Chairman</font></div></td></tr></table></div><div style="padding-right:18pt"><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">POWER OF ATTORNEY</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">&#160;</font></div><div style="text-indent:24.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Each person whose individual signature appears below hereby authorizes David Stack, Charles A. Reinhart, III and Kristen Williams, or any of them, as attorneys-in-fact, with full power of substitution, to execute in the name and on the behalf of each person, individually and in each capacity stated below, and to file, any and all amendments to this registration statement, including any and all post-effective amendments. </font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">&#160;</font></div><div style="text-indent:24.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Pursuant to the requirements of the Securities Act of 1933, this registration statement has been signed by the following persons in the capacities and on the date indicated. </font></div><div style="text-indent:24.5pt"><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#160;</font></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:35.808%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.471%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:39.986%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.192%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:17.843%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Signature</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">&#160;&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Title</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Date</font></td></tr><tr style="height:10pt"><td colspan="3" style="border-top:0.5pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">&#47;s&#47; David Stack</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">David Stack</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Director, Chief Executive Officer and Chairman</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(Principal Executive Officer)</font></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">August 4, 2022</font></td></tr><tr style="height:7pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">&#47;s&#47; Charles A. Reinhart, III</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Charles A. Reinhart, III</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Chief Financial Officer <br>(Principal Financial Officer)</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">August 4, 2022</font></td></tr><tr style="height:9pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">&#47;s&#47; Lauren Riker</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Lauren Riker</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Senior Vice President, Finance <br>(Principal Accounting Officer)</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">August 4, 2022</font></td></tr><tr style="height:9pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">&#47;s&#47; Laura Brege</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Laura Brege</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Director</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">August 4, 2022</font></td></tr><tr style="height:9pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">&#47;s&#47; Christopher Christie</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Christopher Christie</font></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Director</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">August 4, 2022</font></td></tr><tr style="height:9pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">&#47;s&#47; Mark Froimson</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Mark Froimson</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Director</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">August 4, 2022</font></td></tr><tr style="height:9pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">&#47;s&#47; Yvonne Greenstreet</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Yvonne Greenstreet</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Director</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">August 4, 2022</font></td></tr><tr style="height:9pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">&#47;s&#47; Paul Hastings</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Paul Hastings</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Lead Director</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">August 4, 2022</font></td></tr><tr style="height:9pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">&#47;s&#47; Mark Kronenfeld</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Mark Kronenfeld</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Director</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">August 4, 2022</font></td></tr><tr style="height:9pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">&#47;s&#47; Gary Pace</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Gary Pace</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Director</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">August 4, 2022</font></td></tr><tr style="height:9pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">&#47;s Andreas Wicki</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Andreas Wicki</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Director</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">August 4, 2022</font></td></tr></table></div><div style="text-align:center"><font><br></font></div><div style="margin-top:12pt;text-indent:36pt"><font><br></font></div><div style="height:50.4pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-5.1
<SEQUENCE>2
<FILENAME>s-8exhibit51.htm
<DESCRIPTION>EX-5.1
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2022 Workiva -->
<title>Document</title></head><body><div id="i896e1a7eef3f4f7491aafd14e863de00_33"></div><div style="min-height:36pt;width:100%"><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Exhibit 5.1</font></div></div><div><img alt="perkinscoieletterheada.jpg" src="perkinscoieletterheada.jpg" style="height:75px;margin-bottom:5pt;vertical-align:text-bottom;width:775px"></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">August 4, 2022</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">Pacira BioSciences, Inc.</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">5 Sylvan Way, Suite 300</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">Parsippany, New Jersey 07054</font></div><div><font><br></font></div><div style="padding-left:36pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:112%">            Re&#58;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:112%">Registration Statement on Form S-8 of Shares of Common Stock, par value $0.001 per share, of Pacira BioSciences, Inc.</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">Ladies and Gentlemen&#58;</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">We have acted as counsel to Pacira BioSciences, Inc. (the &#8220;Company&#8221;) in connection with the preparation of a Registration Statement on Form S-8 (the &#8220;Registration Statement&#8221;) under the Securities Act of 1933, as amended (the &#8220;Act&#8221;), which you are filing with the Securities and Exchange Commission with respect to an additional 500,000 shares of common stock, $0.001 par value per share (the &#8220;Shares&#8221;) which may be issued pursuant to the Pacira BioSciences, Inc.        </font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">Amended and Restated 2014 Employee Stock Purchase Plan (the &#8220;Plan&#8221;).</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">We have examined the Registration Statement and such documents and records of the Company as we have deemed necessary for the purpose of this opinion. In giving this opinion, we are assuming the authenticity of all instruments presented to us as originals, the conformity with originals of all instruments presented to us as copies and the genuineness of all signatures.</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">Based upon and subject to the foregoing, we are of the opinion that any Shares issued by the Company pursuant to the Plan, upon registration by its registrar of such Shares and the issuance thereof by the Company in accordance with the terms of the Plan, and the receipt of consideration for such Shares in accordance with the terms of the Plan, will be validly issued, fully paid and non-assessable.</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">We hereby consent to the filing of this opinion as an exhibit to the Registration Statement. In giving such consent, we do not admit that we are in the category of persons whose consent is required under Section 7 of the Act.</font></div><div><font><br></font></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:53.226%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:28.226%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.248%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">Very truly yours,</font></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">&#47;s&#47; PERKINS COIE LLP</font></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-23.1
<SEQUENCE>3
<FILENAME>s-8exhibit231.htm
<DESCRIPTION>EX-23.1
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2022 Workiva -->
<title>Document</title></head><body><div id="i76e4070b72f945cbaea69f54b0011719_1"></div><div style="min-height:36pt;width:100%"><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Exhibit 23.1</font></div></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%">CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">We consent to the use of our reports dated February 28, 2022, with respect to the consolidated financial statements of Pacira BioSciences, Inc., and the effectiveness of internal control over financial reporting, incorporated herein by reference.</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">&#47;s&#47; KPMG LLP</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Short Hills, NJ</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">August 4, 2022</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-23.2
<SEQUENCE>4
<FILENAME>exhibit232.htm
<DESCRIPTION>EX-23.2
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2022 Workiva -->
<title>Document</title></head><body><div id="i75728e1f865441eca5f35007083c3837_33"></div><div style="min-height:36pt;width:100%"><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Exhibit 23.2</font></div></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%">CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">We hereby consent to the incorporation by reference in this Registration Statement on Form S-8 of Pacira BioSciences, Inc. of our report dated March 10, 2021, relating to the financial statements of Flexion Therapeutics, Inc., which appears in Flexion Therapeutics, Inc.&#8217;s Annual Report on Form 10-K for the year ended December 31, 2020.</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">&#47;s&#47; PricewaterhouseCoopers LLP</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Boston, Massachusetts</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">August 4, 2022</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-FILING FEES
<SEQUENCE>5
<FILENAME>exhibit107s-8aug2022.htm
<DESCRIPTION>EX-FILING FEES
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2022 Workiva -->
<title>Document</title></head><body><div id="i08a36aa9538b42fba5a4a8befbbf0f58_33"></div><div style="min-height:72pt;width:100%"><div style="text-align:right"><font><br></font></div><div style="text-align:right"><font><br></font></div><div style="text-align:right"><font><br></font></div><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Exhibit 107</font></div></div><div style="padding-left:36pt;padding-right:36pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:115%">CALCULATION OF FILING FEE TABLE</font></div><div style="padding-left:18pt;padding-right:18pt;text-align:center"><font><br></font></div><div style="padding-left:18pt;padding-right:18pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">FORM S-8</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">(Form type)</font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">PACIRA BIOSCIENCES, INC.</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">(Exact name of Registrant as specified in its charter)</font></div><div style="padding-left:18pt;padding-right:18pt;text-align:center"><font><br></font></div><div style="padding-left:18pt;padding-right:18pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline">Table 1&#58; Newly Registered Securities</font></div><div style="padding-left:36pt;padding-right:36pt;text-align:center"><font><br></font></div><div style="padding-left:4.27pt;padding-right:4.27pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:89.903%"><tr><td style="width:1.0%"></td><td style="width:6.921%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:23.320%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.882%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.486%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.199%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.555%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.990%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.847%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:115%">Security<br>Type</font></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:115%">Security<br>Class<br>Title</font></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:115%">Fee<br>Calculation<br>Rule</font></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="padding-left:2.75pt;padding-right:2.75pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:115%">Amount</font></div><div style="padding-left:2.75pt;padding-right:2.75pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:115%">Registered</font></div></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="padding-left:2.75pt;padding-right:2.75pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:115%">Proposed</font></div><div style="padding-left:2.75pt;padding-right:2.75pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:115%">Maximum</font></div><div style="padding-left:2.75pt;padding-right:2.75pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:115%">Offering</font></div><div style="padding-left:2.75pt;padding-right:2.75pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:115%">Price Per</font></div><div style="padding-left:2.75pt;padding-right:2.75pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:115%">Unit  (2)</font></div></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="padding-left:2.75pt;padding-right:2.75pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:115%">Maximum</font></div><div style="padding-left:2.75pt;padding-right:2.75pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:115%">Aggregate</font></div><div style="padding-left:2.75pt;padding-right:2.75pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:115%">Offering</font></div><div style="padding-left:2.75pt;padding-right:2.75pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:115%">Price (2)</font></div></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="padding-left:2.75pt;padding-right:2.75pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:115%">Fee</font></div><div style="padding-left:1.37pt;padding-right:1.37pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Rate</font></div></td><td colspan="3" style="border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="padding-left:2.75pt;padding-right:2.75pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:115%">Amount of Registration</font></div><div style="padding-left:1.37pt;padding-right:1.37pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Fee</font></div></td></tr><tr><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Equity</font></td><td colspan="3" style="border-bottom:1pt solid #000;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Common Stock, $0.001 par value</font></td><td colspan="3" style="border-bottom:1pt solid #000;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">457(c)<br>and<br>457(h)</font></td><td colspan="3" style="border-bottom:1pt solid #000;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">500,000 (1)</font></td><td colspan="3" style="border-bottom:1pt solid #000;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 2.55pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$56.32</font></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$28,160,000.00</font></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">0.0000927</font></td><td colspan="3" style="border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$2,610.43</font></td></tr><tr><td colspan="15" style="border-bottom:1pt solid #000;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Total Offering Amounts</font></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$28,160,000.00</font></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$2,610.43</font></td></tr><tr><td colspan="15" style="border-bottom:1pt solid #000;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Total Fee Offsets</font></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$&#8212;</font></td></tr><tr><td colspan="15" style="border-bottom:1pt solid #000;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Net Fee Due</font></td><td colspan="3" style="border-bottom:1pt solid #000;border-left:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;border-left:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$2,610.43</font></td></tr></table></div><div style="padding-left:54pt;padding-right:27pt;text-indent:-18pt"><font><br></font></div><div style="padding-left:54pt;padding-right:27pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:115%">(1)&#160;&#160;&#160;&#160;Pursuant to Rule 416(a) under the Securities Act of 1933, as amended (the &#8220;Securities Act&#8221;), this registration statement also covers any additional shares of the registrant&#8217;s common stock that may become issuable under the Pacira BioSciences, Inc. Amended and Restated 2014 Employee Stock Purchase Plan as a result of any future stock splits, stock dividends or similar adjustments of the registrant&#8217;s outstanding common stock.</font></div><div style="margin-top:6pt;padding-left:54pt;padding-right:27.35pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:115%">(2)&#160;&#160;&#160;&#160;Estimated solely for the purpose of calculating the registration fee pursuant to Rule&#160;457(c) and Rule 457(h) under the Securities Act. The proposed maximum offering price per share is estimated based on the average of the high and low sales prices for the registrant&#8217;s common stock as reported by the Nasdaq Global Select Market on July 29, 2022.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>6
<FILENAME>perkinscoieletterheada.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 perkinscoieletterheada.jpg
M_]C_X  02D9)1@ ! 0$ E@"6  #_VP!#  ," @," @,# P,$ P,$!0@%!00$
M!0H'!P8(# H,# L*"PL-#A(0#0X1#@L+$!80$1,4%145# \7&!84&!(4%13_
MVP!# 0,$! 4$!0D%!0D4#0L-%!04%!04%!04%!04%!04%!04%!04%!04%!04
M%!04%!04%!04%!04%!04%!04%!04%!3_P  1" !P!/L# 2(  A$! Q$!_\0
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MEWMQIU_#!&8KFUD,<B$RH,AAR."?SKY4^#?PI^,OQH\$0^)M-^*UYI]K+-)
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M.VZCG/U+HI%8,H(.0>012T %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%>6WU[XBTW]H;1+27Q!)/X?U/1K^5-&6W1(H7A>T D+\N[DRR=P "!C.2>&D
M\7>)I-#;X@KXJNTE7Q4-&'AG9#]C-M_:(LC"5V;_ #BI\S?NSG QMXH ^BZ*
M^=-4\6>*X_#^N?$./Q/>(=-\3MI<6@+%%]@>S34%LV1ALWF1AN?S-X(8@ 8&
M"NL>*O%<6@>(/B%'XGO(SI7B>32HM!6*+[ ]G'J LV1QLWF1AN?S-^0Q  P,
M$ ^BJ*\R^.WBZ]\+Z+X?CM]8'AFQU35X;#4-?*(WV"!D=MP+@HC.ZI$'<%5,
MF>N*CNK&?X:^#O$>L:E\0M9U'PXMHL\5U<0P7%U9X/S21RK&!(K KA65L8.#
MS@ 'J-%<=??%CPYID6L&YNI8YM*OX-,N+8PMYQGFV>2J)C+A_,7!'!Y]#CDO
M"_Q\M[A?B'=>(=/OM)T[PSK#:?%/)8N//4I#L10"QDE:23 51R&3 YH ]>HK
MSFS^/'AN32-<O=1AU30+C1EA>[TW5+%X[L+,VV I&-WF>8V5783E@5X/%5I/
MVB/"FF^']<U76H]5\.?V)]G:_LM4L'CN8HYY!'#($7=O1F)&5)Y4@X(Q0!Z?
M17D&O?M#6-OX3\8W%GHVMV7B'1-'EU6'2M6TQX9;B(!@DR)GYX]XPV"&7N!Q
M7.Z;\>)H?B% ]WIGB*^.H^$=/U*+P_I^GO+-&YN+I9IC'G"# C&2V2-H&30!
M] T5S>E^.+/Q5X#_ .$G\-AM7MYK22XM(@K1O*Z@_NRK %6W*5((R""#TKS3
MX06NL>/O#_A[QA;_ !1O]1OYO+GU73DBMGL5)&9;3R @>%D/R@E]X*_-GD4
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M&BU\6>'=!\7>,U\<7&CII< ET/2;&"-K>5P@"QW(="TK32GRP%*X#+M^;)H
M]IHKYZ\6^)/%&L6_Q)UR/Q7=>%Y_!=K'):Z7;K";=Y!9)=.USO0M(KLYC !7
M 0D<\UT'Q)\1>)X9/A?K5CK,FCV&H:O8VU]I,=NA-QYR.65Y&R0JX&%7!R,D
MGI0![+161XLM]9O/#E_!X>O+;3]9ECV6UW=Q&6.%B<;R@^\0,D#H2!GBO)]-
M7Q?HOQ$UOP5I'C*ZULR>'A?_ -H:Y;Q3MIEXTQCC/[M4#+(HD81MT,7'#8H
M]OHKYR\3>-/$7PCN/&5G8>*KGQA'9>&)-5\W5A%*]A>B7RU!,2)\CABPC;IY
M1P<&M75]>\2?!W6;R"3Q+>^+;>;PKJ6M[=82+,=W:"(@H8D3$;^;RG.-HP1D
MT >\45X?X4O_ !+X5\8_#^*_\57WB2#Q997$E]#J$4*I!.D*2J]N(T4QKRR[
M"6&"#U!)]PH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M>77G:/?1)&DD9 W0RF!6)0QME2&(+(Q'J:^T** /R:^%OQ/_ &GO^"=^G3>
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MNJW?%7?$6A^)?C)#96,'A74_#;Z7X8U73;B76U2*-KNYMDACCB*LWF*"K$R
M;<8QDG  -KPWH(^'?Q(^'EOI>I:I-#XBTR\.JIJ%_+="ZECCAD2<B1B%DRS9
M*X!#8QP,>ZUXEX7;7/''Q \#7TWA75O#EMX8TZ[BOY-61$5YY8XHUBA*L?,
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M/BW0=/TXZM83:AIUQIEZUP (6C62&8,BX<":,AERIYZ8Y]+H **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
2HHHH **** "BBB@ HHHH __9

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
